• About us
  • Management
  • Our Partners
  • Career opportunities
  • Contacts
Russian
International
Biotechnology
Center

(495) 988-47-94

(495) 988-47-95

(49243) 7-31-04

info@ibcgenerium.ru

  • Departments
  • Portfolio
  • Fields of research
  • Collaborations

News

February 20, 2015

Alethia Biotherapeutics Submits a Clinical Trial Application (CTA) for a Phase I Study with AB-16B5, an Inhibitor of EMT in Patients with Advanced Cancers

July 2, 2013

XL-protein and GENERIUM sign broad therapeutic license

  • Home
  • /

News

Archive by year:

  • 2015
  • 2014
  • 2013
  • 2012
  • 2011

2 July 2013

XL-protein and GENERIUM sign broad therapeutic license


News 1 - 1 of 2
First | Prev. | 1 2 | Next | Last | All

© 2015, The International Biotechnology Center (IBC) “Generium”

Made in ADV